Analyst stock forecast
Supernus Pharmaceuticals, Inc. Stock Forecast and Analyst Price Target
SUPN analyst target range, upside, consensus rating and coverage count.
Direct answer
Supernus Pharmaceuticals, Inc.'s average price target is $61.75.
The target implies +31.7% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $55.00 to $67.00, with 4 analysts in the current consensus when available.
Forecast evidence checked August 12, 2026.
Get free Supernus Pharmaceuticals, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $46.88
- Average price target
- $61.75
- High price target
- $67.00
- Low price target
- $55.00
- Target upside
- +31.7%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026